MARKET

NCNA

NCNA

Nucana
NASDAQ
0.8900
+0.0172
+1.97%
After Hours: 0.8800 -0.01 -1.12% 19:21 04/01 EDT
OPEN
0.9730
PREV CLOSE
0.8728
HIGH
0.9774
LOW
0.8896
VOLUME
87.90K
TURNOVER
--
52 WEEK HIGH
10.79
52 WEEK LOW
0.6911
MARKET CAP
5.06M
P/E (TTM)
-0.1108
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NCNA last week (0324-0328)?
Weekly Report · 1d ago
Weekly Report: what happened at NCNA last week (0317-0321)?
Weekly Report · 03/24 09:04
NuCana’s Mixed Clinical Results and Financial Caution Lead to Hold Rating
TipRanks · 03/21 13:55
NuCana Reports 2024 Financial Results and Advances Cancer Treatment Programs
TipRanks · 03/20 21:27
NuCana reports Q4 loss per share GBP (0.01) vs GBP (.14)
TipRanks · 03/20 20:55
BRIEF-Nucana Reports Fourth Quarter And Year-End 2024 Financial Results And Provides Business Update
Reuters · 03/20 20:49
NuCana Reports Q4 EPS GBP (1) vs. GBP (14)
TipRanks · 03/20 20:20
NUCANA PLC QTRLY SHR LOSS $0.01
Reuters · 03/20 20:01
More
About NCNA
More
NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline includes NUC-3373, and NUC-7738. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil (5-FU). 5-FU is a prescribed anti-cancer agent. NUC-3373 has been evaluated in a Phase I clinical trial for patients with advanced solid tumors and is under Phase Ib/II clinical trial for patients with advanced colorectal cancer. NUC-7738 is a ProTide transformation of a nucleoside analog, 3’-deoxyadenosine (3’-Da). The Company is evaluating NUC-7738 in a Phase I/II clinical trial for patients with advanced solid tumors. Its pipeline also includes Acelari, which is a ProTide transformation of the nucleoside analog gemcitabine. The Company’s subsidiaries include NuCana, Inc., NuCana Limited and NuCana BioMed Trustee Company Limited.
Recently
Symbol
Price
%Change

Webull offers NuCana PLC (ADR) stock information, including NASDAQ: NCNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NCNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NCNA stock methods without spending real money on the virtual paper trading platform.